Infantile and juvenile presentations of Alexander's disease: a report of two cases

M Deprez1, M D'Hooghe, J P Misson

  • 1Laboratory of Neuropathology, CHU University of Liège, Belgium.

Insights

This study reports two new cases of Alexander's disease in Belgium, a rare genetic neurological disorder. The findings highlight key clinical and pathological features, aiding in diagnosis and understanding of this leukoencephalopathy.

Area of Science:

  • Neurology
  • Genetics
  • Pathology

Background:

  • Alexander's disease is a rare, progressive, and often fatal genetic leukoencephalopathy characterized by demyelination and the accumulation of Rosenthal fibers (RFs) in the central nervous system.
  • The disease typically presents in infancy or childhood, but adult-onset forms exist, presenting a diagnostic challenge.
  • Understanding the genetic basis and pathological mechanisms is crucial for diagnosis and potential therapeutic strategies.

Observation:

  • Two new cases of Alexander's disease are presented, marking the first reported instances in Belgium.
  • Case 1: A 4-year-old girl with megalencephaly, intellectual disability, spastic tetraparesis, ataxia, and epilepsy, with post-mortem findings of widespread myelin loss and RFs.
  • Case 2: A 10-year-old with progressive spastic paraparesis, palatal myoclonus, nystagmus, and spinal deformities, with biopsy confirming numerous RFs and radiological evidence of anterior leukoencephalopathy.

Findings:

  • The cases illustrate the diverse clinical manifestations and pathological hallmarks of Alexander's disease across different age groups.
  • Post-mortem and biopsy findings confirm the presence of widespread myelin loss and Rosenthal fibers, consistent with Alexander's disease.
  • The review of literature and discussion of nosology and pathogenesis provide a comprehensive overview of the condition.

Implications:

  • These cases expand the geographical reporting of Alexander's disease and contribute to the understanding of its clinical spectrum.
  • The study emphasizes the importance of recognizing specific clinical and radiological clues for early diagnosis in living patients.
  • Further research into the pathogeny of RFs and dysmyelination may offer insights into therapeutic targets for Alexander's disease.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...